News

Cadence Partners with VEDP and BRCC for Job Starter Program

Cadence and several other local Shenandoah Valley, Virginia-based manufacturers are teaming up with the Virginia Economic Development Partnership (VEDP) and Blue Ridge Community College for their new Job Starter training program.  Job Starter is a paid training program that allows potential job candidates the opportunity to receive training and meet local employers during a 3-week period.  Ultimately, this program is intended to help members of the community land a career in the advanced manufacturing industry with the employer of their choice.

“It was a great experience to be part of the team of local employers that helped develop this program with Blue Ridge Community College and VEDP,” said Rachel Brown, Human Resources Manager at Cadence’s Virginia facility.  “I believe Job Starter will be an excellent resource for Shenandoah Valley residents that are interested in having a career in advanced manufacturing.”

Job Starter begins October 25 and runs through November 15.  Careers in the program include, but are not limited to, production associates, machine operators, and manufacturing apprentices.  Other local companies participating in the program are Berry Global, Daikin Applied, Dynamic Aviation, Innovative Refrigeration Systems, McKee Foods, and Provides US.

To learn more about Job Starter or to register for this inaugural program, please visit: https://www2.cadenceinc.com/BRCCjobstarter.

Recent News

06/29/2022

Bio-plastics startup wins Lighthouse Labs pitch contest

Charlottsville, VA (Virginia Business) – While pitching to the sharks, entrepreneur Alec Brewer told them, “I do have white powder in my pocket,” before quickly clarifying that it wasn’t an illicit substance: “It’s PHB! It’s PHB!” The co-founder and CEO of Charlottesville-based biodegradable plastics manufacturer Ourobio, Brewer explained that his company makes PHB, or polyhydroxybutyrate,

06/26/2022

USA FDA Grants Fast Track Designation to ReAlta Life Sciences’ Lead Compound RLS-0071

ReAlta Life Sciences (“ReAlta”), Inc., a clinical stage, rare disease company dedicated to harnessing the power of the immune system to address life threatening diseases, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to RLS-0071 for the treatment of hypoxic ischemic encephalopathy (HIE). RLS-0071 is the Company’s lead dual

06/20/2022

Adial Pharmaceuticals Awarded Additional U.S. Patent Combining the Use of the Company’s Proprietary Genetic Diagnostic With AD04 to Treat Alcohol and Drug Dependence

New patent covers the use of the full genetic panel measuring all five genetic biomarkers CHARLOTTESVILLE, Va., — Adial Pharmaceuticals, Inc. (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced patent number 11,351,154 was issued on June 7, 2022, by